Torsdag 28 November | 05:52:53 Europe / Stockholm

Kalender

Tid*
2025-10-29 N/A 15-10 2025-Q3
2025-08-12 08:00 Kvartalsrapport 2025-Q2
2025-04-30 N/A 15-10 2025-Q1
2025-04-10 N/A Årsstämma
2025-02-12 N/A Bokslutskommuniké 2024
2024-11-01 - 15-10 2024-Q3
2024-10-24 - Extra Bolagsstämma 2024
2024-08-09 - Kvartalsrapport 2024-Q2
2024-04-29 - 15-10 2024-Q1
2024-04-12 - Årsstämma
2024-04-12 - X-dag ordinarie utdelning REMEDY 0.00 EUR
2024-03-20 - Bokslutskommuniké 2023
2023-10-31 - 15-10 2023-Q3
2023-08-11 - Kvartalsrapport 2023-Q2
2023-04-26 - 15-10 2023-Q1
2023-04-14 - X-dag ordinarie utdelning REMEDY 0.10 EUR
2023-04-13 - Årsstämma
2023-02-10 - Bokslutskommuniké 2022
2022-10-28 - 15-10 2022-Q3
2022-08-12 - Kvartalsrapport 2022-Q2
2022-05-13 - 15-10 2022-Q1
2022-04-14 - X-dag ordinarie utdelning REMEDY 0.17 EUR
2022-04-13 - Årsstämma
2022-02-11 - Bokslutskommuniké 2021
2021-11-12 - 15-10 2021-Q3
2021-08-13 - Kvartalsrapport 2021-Q2
2021-04-15 - X-dag ordinarie utdelning REMEDY 0.15 EUR
2021-04-14 - Årsstämma
2021-02-12 - Bokslutskommuniké 2020
2020-08-14 - Kvartalsrapport 2020-Q2
2020-04-07 - X-dag ordinarie utdelning REMEDY 0.11 EUR
2020-04-06 - Årsstämma
2020-02-14 - Bokslutskommuniké 2019
2019-08-13 - Kvartalsrapport 2019-Q2
2019-04-09 - X-dag ordinarie utdelning REMEDY 0.10 EUR
2019-04-08 - Årsstämma
2019-02-12 - Bokslutskommuniké 2018
2018-08-01 - Kvartalsrapport 2018-Q2
2018-04-04 - X-dag ordinarie utdelning REMEDY 0.00 EUR
2018-02-16 - Bokslutskommuniké 2017
2017-08-16 - Kvartalsrapport 2017-Q2

Beskrivning

LandFinland
ListaMid Cap Helsinki
SektorSällanköp
IndustriGaming
Remedy Entertainment är en spelutvecklare. Verksamheten är främst inriktad mot utveckling av actionspel, med särskilt fokus på 3D-teknik. Exempel på spel som bolaget utvecklat inkluderar ett flertal olika versioner av Alan Wake, Max Payne, samt Control. Remedy utvecklar också sin egen spelmotor och verktygsteknologi som driver många av spelen. Bolaget grundades år 1995 och har sitt huvudkontor i Esbo.
2024-10-24 13:00:00

Remedy Entertainment Plc      Stock Exchange Release      October 24, 2024 at 2.00 p.m. EEST

The Board of Directors of Remedy decided on issuance of special rights to Tencent

The Board of Directors of Remedy Entertainment Plc has, by virtue of the authorization granted by the Extraordinary General Meeting held on October 24, 2024, decided to issue special rights to Image Frame Investment (HK) Limited, an affiliate of Tencent Holdings Ltd. The special rights are related to the EUR 15 million convertible loan under the Convertible Loan Agreement that Remedy signed with Tencent on 27 September 2024. The Extraordinary General Meeting held on October 24, 2024, approved the material terms and conditions of the convertible loan. There is a weighty financial reason to issue the special rights as the purpose of the convertible loan issued under the Convertible Loan Agreement is to support the company’s working capital needs and secure the company’s liquidity.

The maximum total number of special rights issued is 811,100, entitling the lender of the convertible loan to subscribe for a maximum of 811,100 new shares of the company. The special rights will be granted without payment. The share subscription period with the special rights will begin on the third anniversary of the date when Tencent paid the convertible loan amount to Remedy and ends on the fifth anniversary of the said date.

The subscription price for a share subscribed for with one special right is EUR 27.20, as agreed between the parties in the Convertible Loan Agreement. The subscription price for the shares shall be paid in full at the time of subscription by way of set-off against the convertible loan and accrued interest in an amount corresponding to the aggregate subscription price payable for the subscribed shares. The lender may choose to exercise the special rights only with respect to part of the convertible loan and accrued interest and/or in several instalments at any time during the share subscription period.

The subscription price of the shares shall be credited entirely in the reserve for invested unrestricted equity of the company. To the extent the convertible loan together with accrued interest cannot otherwise be converted into shares in their entirety due to the reason that partial shares cannot be issued, the number of shares that would otherwise be issued to the lender shall be rounded up to the nearest full number.

The number of the company’s shares may increase at maximum by 811,100 shares as a result of the share subscriptions with the special rights, equaling 5.64 percent of all shares and votes in the company after the possible share subscription, if only new shares are issued in the subscription.

The terms and conditions of special rights are attached to this release and will be available on the company’s website at https://investors.remedygames.com/extraordinary-general-meeting-2024/.

REMEDY ENTERTAINMENT PLC

More Information
Eloranta, Investor Relations Manager
Phone: +358 50 4334992
Email: liisa.eloranta@remedygames.com

Distribution
Nasdaq Helsinki Ltd.
Key media

Remedy in brief
Remedy Entertainment Plc is a pioneering, globally renowned video game company founded in 1995 and headquartered in Finland with an office in Stockholm, Sweden. Known for its story-driven and visually stunning action games, Remedy has created multiple successful, critically acclaimed franchises such as Control, Alan Wake and Max Payne. Remedy also develops its own Northlight game engine and tools technology that powers many of its games. Remedy’s shares are listed on Nasdaq Helsinki’s official list.

www.remedygames.com